Justin Walsh

Andre Uddin

Carvey Leung

- **Theratechnologies Inc.** announced the **completion of its acquisition** by CB Biotechnology, LLC, an affiliate of **Future Pak, LLC**, on **September 25, 2025**.  **[1512717_0001193125-25-217171_d49314dex991.htm:0]** 
- Shareholders received **US$3.01 per Share in cash** plus **one contingent value right (CVR) per Share**.  **[1512717_0001193125-25-217171_d49314dex991.htm:0]** 
- Each CVR has a **fair market value of US$0.80** as of September 24, 2025, and entitles the holder to **additional aggregate cash payments of up to US$1.19 per CVR** if certain milestones are achieved.  **[1512717_0001193125-25-217171_d49314dex991.htm:0]** 
- The company's shares are expected to be **de-listed from the Toronto Stock Exchange on or about September 26, 2025**, and from the **Nasdaq Capital Market on or about September 25, 2025**.  **[1512717_0001193125-25-217171_d49314dex991.htm:0]**

Theratechnologies Completes Acquisition by Future Pak

- Theratechnologies Inc. has received **final court approval** from the Superior Court of Québec for its previously announced **plan of arrangement** to be acquired by **CB Biotechnology, LLC**, an affiliate of Future Pak, LLC.  **[1512717_0001193125-25-205635_d29971dex991.htm:0]** 
- This final court approval follows the **shareholder approval** obtained on **September 12, 2025**.  **[1512717_0001193125-25-205635_d29971dex991.htm:0]** 
- The company anticipates the arrangement will be completed on or about **September 25, 2025**, subject to the satisfaction of remaining closing conditions.  **[1512717_0001193125-25-205635_d29971dex991.htm:0]**

Theratechnologies Receives Final Court Approval for Acquisition by Future Pak

- Theratechnologies Inc. shareholders have **approved a plan of arrangement** for the company to be **acquired by CB Biotechnology, LLC**, an affiliate of Future Pak, LLC.  **[1512717_0001193125-25-202066_d83861dex991.htm:0]** 
- The arrangement resolution was approved by **97.44%** of the votes cast by shareholders.  **[1512717_0001193125-25-202066_d83861dex991.htm:0]** 
- The proposed acquisition remains subject to customary closing conditions, including a **final order by the Superior Court of Québec** following a hearing expected on **September 16, 2025**.  **[1512717_0001193125-25-202066_d83861dex991.htm:0]**

Theratechnologies Shareholders Approve Acquisition by Future Pak Affiliate

- Theratechnologies shareholders have **approved** the previously announced plan of arrangement to be acquired by CB Biotechnology, LLC, an affiliate of Future Pak, LLC.  **[1512717_d5c882e4656540688cfa4e19c875829a_0]** 
- The arrangement resolution received overwhelming support, with **97.44%** of votes cast by shareholders approving it.  **[1512717_d5c882e4656540688cfa4e19c875829a_0]** 
- The proposed arrangement remains subject to customary closing conditions, including a final order from the Superior Court of Québec, with a hearing anticipated on **September 16, 2025**.  **[1512717_d5c882e4656540688cfa4e19c875829a_0]**

Theratechnologies (THTX)